68.59 USD
-0.59 (-0.85%)
68.59 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to CRVL. CRVL was compared to 102 industry peers in the Health Care Providers & Services industry. CRVL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, CRVL is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- CRVL had positive earnings in the past year.
- CRVL had a positive operating cash flow in the past year.
- In the past 5 years CRVL has always been profitable.
- CRVL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 17.22%, CRVL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 29.03%, CRVL belongs to the top of the industry, outperforming 93.14% of the companies in the same industry.
- With an excellent Return On Invested Capital value of 28.20%, CRVL belongs to the best of the industry, outperforming 99.02% of the companies in the same industry.
- CRVL had an Average Return On Invested Capital over the past 3 years of 28.60%. This is significantly above the industry average of 9.21%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.22% | ||
| ROE | 29.03% | ||
| ROIC | 28.2% |
ROA(3y)17.02%
ROA(5y)15.59%
ROE(3y)31.06%
ROE(5y)29.09%
ROIC(3y)28.6%
ROIC(5y)26.25%
1.3 Margins
- With an excellent Profit Margin value of 11.28%, CRVL belongs to the best of the industry, outperforming 96.08% of the companies in the same industry.
- In the last couple of years the Profit Margin of CRVL has grown nicely.
- CRVL has a Operating Margin of 14.49%. This is amongst the best in the industry. CRVL outperforms 86.27% of its industry peers.
- In the last couple of years the Operating Margin of CRVL has grown nicely.
- CRVL has a Gross Margin (24.20%) which is comparable to the rest of the industry.
- CRVL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.49% | ||
| PM (TTM) | 11.28% | ||
| GM | 24.2% |
OM growth 3Y1.04%
OM growth 5Y5.65%
PM growth 3Y1.12%
PM growth 5Y5.84%
GM growth 3Y-0.17%
GM growth 5Y1.95%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CRVL is creating value.
- Compared to 1 year ago, CRVL has about the same amount of shares outstanding.
- The number of shares outstanding for CRVL has been reduced compared to 5 years ago.
- CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 13.32 indicates that CRVL is not in any danger for bankruptcy at the moment.
- The Altman-Z score of CRVL (13.32) is better than 97.06% of its industry peers.
- There is no outstanding debt for CRVL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 13.32 |
ROIC/WACC3.16
WACC8.92%
2.3 Liquidity
- A Current Ratio of 1.89 indicates that CRVL should not have too much problems paying its short term obligations.
- With a decent Current ratio value of 1.89, CRVL is doing good in the industry, outperforming 79.41% of the companies in the same industry.
- CRVL has a Quick Ratio of 1.89. This is a normal value and indicates that CRVL is financially healthy and should not expect problems in meeting its short term obligations.
- CRVL's Quick ratio of 1.89 is amongst the best of the industry. CRVL outperforms 80.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.89 | ||
| Quick Ratio | 1.89 |
3. Growth
3.1 Past
- CRVL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.77%, which is quite impressive.
- CRVL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.86% yearly.
- Looking at the last year, CRVL shows a quite strong growth in Revenue. The Revenue has grown by 10.43% in the last year.
- The Revenue has been growing by 8.62% on average over the past years. This is quite good.
EPS 1Y (TTM)31.77%
EPS 3Y14.48%
EPS 5Y16.86%
EPS Q2Q%22.61%
Revenue 1Y (TTM)10.43%
Revenue growth 3Y11.49%
Revenue growth 5Y8.62%
Sales Q2Q%6.8%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- CRVL is valuated quite expensively with a Price/Earnings ratio of 33.79.
- The rest of the industry has a similar Price/Earnings ratio as CRVL.
- When comparing the Price/Earnings ratio of CRVL to the average of the S&P500 Index (27.38), we can say CRVL is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.79 | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRVL is on the same level as its industry peers.
- CRVL's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.74 | ||
| EV/EBITDA | 19.95 |
4.3 Compensation for Growth
- CRVL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- CRVL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
68.59
-0.59 (-0.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-03 2025-11-03
Earnings (Next)02-02 2026-02-02
Inst Owners54.85%
Inst Owner Change-0.05%
Ins Owners7.08%
Ins Owner Change-0.6%
Market Cap3.52B
Revenue(TTM)933.84M
Net Income(TTM)105.33M
Analysts0
Price TargetN/A
Short Float %1.97%
Short Ratio3.2
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.79 | ||
| Fwd PE | N/A | ||
| P/S | 3.76 | ||
| P/FCF | 34.74 | ||
| P/OCF | 24.31 | ||
| P/B | 9.69 | ||
| P/tB | 10.8 | ||
| EV/EBITDA | 19.95 |
EPS(TTM)2.03
EY2.96%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.97
FCFY2.88%
OCF(TTM)2.82
OCFY4.11%
SpS18.22
BVpS7.08
TBVpS6.35
PEG (NY)N/A
PEG (5Y)2
Graham Number17.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.22% | ||
| ROE | 29.03% | ||
| ROCE | 35.48% | ||
| ROIC | 28.2% | ||
| ROICexc | 61.83% | ||
| ROICexgc | 78.64% | ||
| OM | 14.49% | ||
| PM (TTM) | 11.28% | ||
| GM | 24.2% | ||
| FCFM | 10.84% |
ROA(3y)17.02%
ROA(5y)15.59%
ROE(3y)31.06%
ROE(5y)29.09%
ROIC(3y)28.6%
ROIC(5y)26.25%
ROICexc(3y)48.46%
ROICexc(5y)45.93%
ROICexgc(3y)62.9%
ROICexgc(5y)61.44%
ROCE(3y)35.98%
ROCE(5y)33.03%
ROICexgc growth 3Y4.75%
ROICexgc growth 5Y18.9%
ROICexc growth 3Y6.87%
ROICexc growth 5Y18.29%
OM growth 3Y1.04%
OM growth 5Y5.65%
PM growth 3Y1.12%
PM growth 5Y5.84%
GM growth 3Y-0.17%
GM growth 5Y1.95%
F-Score8
Asset Turnover1.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 142.2% | ||
| Cap/Sales | 4.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 87.2% | ||
| Profit Quality | 96.07% | ||
| Current Ratio | 1.89 | ||
| Quick Ratio | 1.89 | ||
| Altman-Z | 13.32 |
F-Score8
WACC8.92%
ROIC/WACC3.16
Cap/Depr(3y)112.41%
Cap/Depr(5y)107.09%
Cap/Sales(3y)3.78%
Cap/Sales(5y)3.81%
Profit Quality(3y)90.78%
Profit Quality(5y)99.01%
High Growth Momentum
Growth
EPS 1Y (TTM)31.77%
EPS 3Y14.48%
EPS 5Y16.86%
EPS Q2Q%22.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.43%
Revenue growth 3Y11.49%
Revenue growth 5Y8.62%
Sales Q2Q%6.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.09%
EBIT growth 3Y12.65%
EBIT growth 5Y14.76%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y40.64%
FCF growth 3Y34.78%
FCF growth 5Y13.57%
OCF growth 1Y48.85%
OCF growth 3Y23.73%
OCF growth 5Y9.51%
CORVEL CORP / CRVL FAQ
What is the ChartMill fundamental rating of CORVEL CORP (CRVL) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CRVL.
Can you provide the valuation status for CORVEL CORP?
ChartMill assigns a valuation rating of 2 / 10 to CORVEL CORP (CRVL). This can be considered as Overvalued.
What is the profitability of CRVL stock?
CORVEL CORP (CRVL) has a profitability rating of 9 / 10.
Can you provide the financial health for CRVL stock?
The financial health rating of CORVEL CORP (CRVL) is 9 / 10.